Teiko is excited to announce that two posters have been accepted for presentation at the 2024 Society for Immunotherapy of Cancer (SITC) annual meeting in Houston from November 8 - 10th.
Teiko is excited to announce that two posters have been accepted for presentation at the 2024 Society for Immunotherapy of Cancer (SITC) annual meeting in Houston from November 8 - 10th.
Teiko will present its work on optimizing fixed whole blood samples for mass cytometry, highlighting the development and validation of the TokuKit, a two-step collection kit that stabilizes whole blood for long-term storage at -80°C for up to 24 months. The poster will show inter- and intra-run validation for a 41+ marker pan-immunophenotyping panel and performance comparisons to fresh blood, supporting the use of the TokuKit in clinical trials for biomarker research and immune monitoring.
In addition, Teiko will also highlight its research on addressing the challenge of processing fresh blood for flow cytometry in clinical trials by optimizing the TokuKit fixation method for high-dimensional immune profiling using a 20+-marker spectral flow cytometry panel, which shows comparable (r=0.975) results to freshly processed samples.
Abstract Title: It’s about time: Rapid on-site fixation of whole blood samples prior to high-dimensional flow cytometric analysis
Abstract Number: 57
Presenter: Kristina Magee, MD-PhD, Associate Director Lab Operations
Poster Presentation Date: Friday, Nov. 8 from 12:15 - 1:45PM, 5:30PM - 7:00PM
Read the poster here.
Watch the presentation here.
Abstract Title: It’s on-site: eliminating site-to-site variability with whole blood collection kits using 40+ marker TokuProfile mass cytometry assay
Abstract Number: 58
Presenter: Justin Jarrell, PhD, VP Business Development
Poster Presentation Date: Saturday, Nov. 9 from 12:15PM - 1:45PM, 7:00PM - 8:30PM
Read the poster here.
Watch the presentation here.
